Advertisement
Advertisement
AXSM
Axsome Therapeutics, Inc
107.24
USD+0.91
+0.86%
Apr 28, 15:59 UTC -4
Closed
Pre-Market
107.65
+0.41
+0.39%
Axsome Therapeutics, Inc Profile
About
Info & Links
CEO
Herriot Tabuteau
Headquarters
NEW YORK, NY 10007, UNITED STATES
Industry
Sector
Website
Auditor
Deloitte & Touche LLP
Share holders
2
Employees
683
Axsome Therapeutics, Inc Statistics
Valuation Measures
Market Capitalization2
5.25B
Enterprise Value
5.12B
Enterprise Value/EBITDA(ttm)
-18.96
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
16.32
Price to Book(mrq)
109.73
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
91.36%
Operating Margin(ttm)
-57.49%
Profit Margin(ttm)
-76.73%
Return on Equity(ttm)
-223.51%
Return on Invested Capital(ttm)
-103.44%
Return on Assets(ttm)
-39.88%
Income Statement
Revenue(ttm)
385.69M
Revenue Per Share(ttm)
7.91
Gross Profit(ttm)
352.39M
EBITDA(ttm)3
-269.96M
Net Income Available to Common(ttm)
-287.22M
Diluted EPS(ttm)
-5.99
Share Statistics
Beta (5Y Monthly)
1.05
52-Week Change
49.55%
S&P 500 52-Week Change
8.06%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
48.77M
Dividend Yield
0.00%
Float4
37.84M
% Held by Insiders
22.40%
% Held by Institutions
81.49%
Balance Sheet
Total Cash(mrq)
315.35M
Total Cash Per Share(mrq)
6.47
Total Debt(mrq)
183.65M
Total Debt/Equity(mrq)
322.11%
Current Ratio(mrq)
2.11%
Quick Ratio(mrq)
2.37%
Book Value Per Share(mrq)
1.17
Cash Flow
Operating Cash Flow Per Share(ytd)
-2.68
Free Cash Flow(ytd)
-128.68M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement